Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001014763-12-000018
Filing Date
2012-08-09
Accepted
2012-08-09 11:55:40
Documents
10
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q 6-30-12 form10q_06302012.htm 10-Q 373523
2 EXHIBIT 31.1A 6-30-12 exhibit31-1a_06302012.htm EX-31.1A 12581
3 EXHIBIT 31.1B 6-30-12 exhibit31-1b_06302012.htm EX-31.1B 12528
4 EXHIBIT 32.1 6-30-12 exhibit32-1_06302012.htm EX-32.1 8808
  Complete submission text file 0001014763-12-000018.txt   2304929

Data Files

Seq Description Document Type Size
5 EXHIBIT 101.INS 6-30-12 amar-20120630.xml EX-101.INS 227002
6 EXHIBIT 101.SCH 6-30-12 amar-20120630.xsd EX-101.SCH 28340
7 EXHIBIT 101.CAL 6-30-12 amar-20120630_cal.xml EX-101.CAL 19559
8 EXHIBIT 101.DEF 6-30-12 amar-20120630_def.xml EX-101.DEF 145467
9 EXHIBIT 101.LAB 6-30-12 amar-20120630_lab.xml EX-101.LAB 179075
10 EXHIBIT 101.PRE 6-30-12 amar-20120630_pre.xml EX-101.PRE 149662
Mailing Address AMARILLO BIOSCIENCES INC 4134 BUSINESS PARK DRIVE AMARILLO TX 79110-4225
Business Address AMARILLO BIOSCIENCES INC 4134 BUSINESS PARK DRIVE AMARILLO TX 79110-4225 (806) 376-1741
AMARILLO BIOSCIENCES INC (Filer) CIK: 0001014763 (see all company filings)

EIN.: 751974352 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-20791 | Film No.: 121019292
SIC: 2834 Pharmaceutical Preparations